Format

Send to

Choose Destination
See comment in PubMed Commons below
J Thorac Dis. 2014 Mar;6(3):249-57. doi: 10.3978/j.issn.2072-1439.2013.11.18.

Surgical indications and optimization of patients for resectable esophageal malignancies.

Author information

  • 1Division of Thoracic Surgery, The Johns Hopkins University, School of Medicine, Baltimore, Maryland 21287, USA.

Abstract

Esophageal cancer is a devastating diagnosis with very dire long-term survival rates. This is largely due to its rather insidious progression, which leads to most patients being diagnosed with advanced disease. Recently, however, a greater understanding of the pathogenesis of esophageal malignancies has afforded surgeons and oncologists with new opportunities for intervention and management. Coupled with improvements in imaging, staging, and medical therapies, surgeons have continued to enhance their knowledge of the nuances of esophageal resection, which has resulted in the development of minimally invasive approaches with similar overall oncologic outcomes. This marriage of more efficacious induction therapy and diminished morbidity after esophagectomy offers new promise to patients diagnosed with this aggressive form of cancer. The following review will highlight these most recent advances and will offer insight into our own approach to patients with resectable esophageal malignancy.

KEYWORDS:

Esophageal cancer; indication for surgery; preoperative optimization; review

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for AME Publishing Company Icon for PubMed Central
    Loading ...
    Write to the Help Desk